FRUSCIO, ROBERT
 Distribuzione geografica
Continente #
NA - Nord America 20.946
AS - Asia 12.608
EU - Europa 10.849
SA - Sud America 2.092
AF - Africa 216
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 25
Totale 46.790
Nazione #
US - Stati Uniti d'America 20.412
SG - Singapore 3.661
CN - Cina 3.298
IT - Italia 2.394
HK - Hong Kong 2.322
RU - Federazione Russa 1.986
VN - Vietnam 1.634
BR - Brasile 1.632
DE - Germania 1.226
IE - Irlanda 1.170
SE - Svezia 1.045
UA - Ucraina 684
GB - Regno Unito 612
FR - Francia 388
CA - Canada 359
FI - Finlandia 305
ID - Indonesia 305
IN - India 276
KR - Corea 257
TR - Turchia 217
AT - Austria 195
NL - Olanda 184
JP - Giappone 145
AR - Argentina 142
ES - Italia 136
MX - Messico 126
BD - Bangladesh 108
CO - Colombia 90
DK - Danimarca 90
PL - Polonia 82
ZA - Sudafrica 79
IQ - Iraq 70
EC - Ecuador 67
BE - Belgio 64
AU - Australia 45
CH - Svizzera 44
EG - Egitto 41
CL - Cile 40
VE - Venezuela 37
GR - Grecia 36
PE - Perù 36
SA - Arabia Saudita 36
PT - Portogallo 34
IR - Iran 32
MA - Marocco 32
CZ - Repubblica Ceca 30
SK - Slovacchia (Repubblica Slovacca) 29
TH - Thailandia 28
PK - Pakistan 25
PH - Filippine 24
RO - Romania 24
AE - Emirati Arabi Uniti 22
PY - Paraguay 22
LT - Lituania 19
UY - Uruguay 19
BG - Bulgaria 18
IL - Israele 18
UZ - Uzbekistan 17
EU - Europa 15
KE - Kenya 13
LV - Lettonia 11
MY - Malesia 11
TW - Taiwan 11
AL - Albania 10
JM - Giamaica 10
DZ - Algeria 9
HN - Honduras 9
LK - Sri Lanka 9
OM - Oman 9
TN - Tunisia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
JO - Giordania 8
AZ - Azerbaigian 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GT - Guatemala 6
KW - Kuwait 6
NG - Nigeria 6
NP - Nepal 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
HU - Ungheria 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
BA - Bosnia-Erzegovina 4
CI - Costa d'Avorio 4
HR - Croazia 4
KH - Cambogia 4
MD - Moldavia 4
QA - Qatar 4
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
KG - Kirghizistan 3
LB - Libano 3
MK - Macedonia 3
NI - Nicaragua 3
Totale 46.742
Città #
Ann Arbor 3.294
Singapore 2.338
Hong Kong 2.285
Ashburn 1.745
Woodbridge 1.570
Fairfield 1.493
Dublin 1.112
Houston 1.086
Chandler 948
Wilmington 824
Jacksonville 692
Seattle 648
Frankfurt am Main 616
Hefei 601
Milan 557
New York 556
Cambridge 520
Santa Clara 518
Dearborn 488
Ho Chi Minh City 476
Dallas 463
Princeton 426
Beijing 403
Hanoi 389
Los Angeles 325
Jakarta 259
Seoul 239
Hangzhou 222
Moscow 210
Nanjing 210
Lawrence 191
Shanghai 182
Altamura 170
Chicago 169
Boardman 162
Buffalo 147
Vienna 138
São Paulo 130
Lachine 112
Rome 105
San Diego 103
Nuremberg 99
Guangzhou 95
Munich 89
Helsinki 88
London 88
Lissone 85
Tokyo 83
Nanchang 79
Council Bluffs 69
Ottawa 64
Andover 62
Toronto 60
Lappeenranta 59
Rio de Janeiro 57
Shenyang 57
Dong Ket 56
Brooklyn 55
Fremont 52
Istanbul 51
Changsha 48
Kent 48
Montreal 48
Salt Lake City 46
Warsaw 46
Jinan 45
Da Nang 44
Hebei 44
Chennai 43
Haiphong 43
Brussels 41
Johannesburg 41
Columbus 39
Denver 38
Atlanta 37
Kunming 37
Amsterdam 36
Belo Horizonte 36
San Francisco 36
Tianjin 36
Turku 36
Ankara 35
Falls Church 34
Ha Long 34
Mexico City 34
The Dalles 34
Brasília 33
Ninh Bình 33
Norwalk 32
Porto Alegre 32
Quận Bình Thạnh 32
Zhengzhou 32
Düsseldorf 31
Phoenix 31
Pune 31
Biên Hòa 30
Boston 30
Poplar 30
Florence 29
Stockholm 29
Totale 29.944
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 958
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 842
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 496
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 460
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 457
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 435
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 400
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 370
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 369
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 365
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 358
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 336
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 335
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 331
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 300
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 297
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 297
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 295
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 290
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 289
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 275
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 273
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 273
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 272
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 265
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 263
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 260
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 259
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 258
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 258
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 254
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 246
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 245
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 242
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 242
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 241
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 240
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 238
Delaying surgery for patients with a previous SARS-CoV-2 infection 238
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 235
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 230
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 230
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 228
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 223
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 219
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 216
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 214
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 214
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 214
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 213
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 213
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 211
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 211
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 210
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 210
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 210
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 209
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 209
Synchronous early-stage endometrial and ovarian cancer 208
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 208
PRL-3 phosphatase is implicated in ovarian cancer growth 207
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 205
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 205
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 205
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 204
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 203
Managing Ovarian tumors during pregnancy 202
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 199
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 195
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 195
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 195
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 192
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa 191
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 186
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 185
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 182
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 182
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 181
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer 181
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 180
Borderline ovarian cancer 180
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 179
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 179
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 178
Prognosis of patients with cervical cancer diagnosed during pregnancy 178
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 177
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 177
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 177
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 176
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 176
The role of transvaginal ultrasound in the workup of invasive molar disease 175
Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumour Analysis) 4 cohort 175
Melanoma during pregnancy: A report of 60 pregnancies complicated by melanoma 174
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts 173
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 172
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery 170
Systematic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgery and chemotherapy: a retrospective study 170
Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy 169
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 168
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study 168
Totale 25.023
Categoria #
all - tutte 172.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.980 0 0 0 0 326 355 427 496 374 424 226 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202610.735 3.093 2.037 1.923 2.581 1.101 0 0 0 0 0 0 0
Totale 48.068